EECP (Enhanced External Counter Pulsation) benefits sustained at two years:
This article was originally published in Clinica
Executive Summary
Vasomedical says that data is now available to show that the reduction in angina achieved using its Enhanced External Counter Pulsation (EECP) therapy is sustained at two years. The results come from an analysis of 254 patients from an International EECP patient registry at the University of Pittsburgh Graduate School of Public Health in Pennsylvania. Before EECP therapy, 80% of patients had severe angina. This figure fell to 16% immediately following treatment and remained at this level for the next two years, says the Westbury, New York firm.